| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Institute of Medical Immunology, Charité, Medical University Berlin, Berlin, Germany
 |
Abstract |
|---|
 Top Abstract Materials and MethodsResultsDiscussionReferences |
|---|
-producing T cells specific for paternal antigens compared to those from normal pregnancy (7.8% versus 2.7%, P < 0.05). Compared to virgin CBA/J females, normal pregnant mice showed strongly elevated numbers of CD4+CD25+ and interleukin-10+ Treg cells in the thymus whereas significantly lower frequencies of Treg cells were observed in abortion mice. Very interestingly, CD4+CD25+ Treg cells from normal pregnant and nonpregnant CBA/J mice could inhibit both proliferation and interferon- secretion of lymphocytes from abortion mice in vitro whereas in vivo prevention of fetal rejection could only be achieved after adoptive transfer of Treg cells from normal pregnant mice. Our data suggest that pregnancy-induced Treg cells play a vital role in maternal tolerance to the allogeneic fetus.
Local mechanisms may play an important role in evading immune attack because maternal alloreactive lymphocytes are not systemically depleted. The specialized fetal tissue in contact with maternal uterine tissue might contribute to tolerance by several mechanisms, such as depleting tryptophan,3
by inactivating natural killer cells through HLA-G expression,4
or by provoking apoptosis of activated maternal lymphocytes.5
Incomplete tolerance might therefore result in disturbed pregnancy such as spontaneous abortion and pre-eclampsia. Further, Th1/Th2 cytokine balance has been seen as a very important mechanism determining the survival of the fetus in the maternal uterus6-10
because the production of Th2-type cytokines such as interleukin (IL)-4 and IL-10 locally at the feto-maternal interface would favor the maintenance of mammalian pregnancy11,12
and a Th1/proinflammatory predominant pattern [up-regulation of IL-2, IL-6, interferon (IFN)-, and tumor necrosis factor (TNF)-
] would mediate the fetal rejection.13-17
However, IL-4 and IL-10 genetically deficient mice do not show disturbed pregnancy,18
suggesting that Th2 cells are not essential for normal pregnancy and alloreactive Th1 cells must be differently regulated, as already proposed.19-21
Similar challenges of the Th1/Th2 concept have been made for organ allografts as tolerance induction in IL-4–/– mice develops normally.22
CD4+CD25+ Treg cells were recently described as a unique subpopulation of T cells, 23-25 known to play a major role in preventing autoimmunity and tolerating allogeneic organ grafts.26,27 The role of Treg cells in physiology and pathophysiology of pregnancy is still unclear. The acceptance of paternally derived tumors cells during pregnancy2 supports the involvement of systemic regulatory processes in pregnancy, and encourages one to design studies aiming to clarify the role of Treg cells during pregnancy.
The CBA/J x DBA/2J murine model offers the possibility to elucidate mechanisms underlying immunological spontaneous abortion because the mating of CBA/J females (H2k) with DBA/2J males (H2d) provokes spontaneously high abortion rates, whereas mating CBA/J females with BALB/c mice, which also bear H2d antigens, ends in completely normal pregnancies.28 Here, we wondered whether a functional deficiency of Treg cells contributes to the spontaneous abortion in this model and whether fetal rejection could be prevented by adoptive transfer of Treg cells from normal pregnant or nonpregnant mice into pregnant abortion-prone mice.
|
Materials and Methods |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
Male DBA/2J mice were purchased from Charles River (Wilmington, MA) and female CBA/J were purchased from Charles River (Les Oncins, France) through Charles River, Sulzfeld, Germany. BALB/c males were acquired from Harlan Winkelmann (Borchen, Germany). All animals were housed in a barrier facility. Animal care and experimental procedures were followed according to institutional guidelines and conformed to requirement of the state authority for animal research conduct (LaGetSi, Berlin, 0070/03). An immunological model of abortion was used, in which the mating combination CBA/J x DBA/2J represents the abortion group, using the combination CBA/J x BALB/c as a normal pregnancy control.28 Two-month-old CBA/J females were paired with 2- to 4-month-old BALB/c or DBA/2J males, checked twice a day for vaginal plugs and separated from the males if mated. The day of the vaginal plug was considered as day 0 of pregnancy. The animals included in the first part of the study received no treatment.
In the second part of the study, pregnant CBA/J females mated with BALB/c were considered as group 1 and received phosphate-buffered saline (PBS) intravenously (n = 28). DBA/2J-mated females were then randomized and divided in the following groups: group 2, abortion group + PBS intravenously (n = 28); group 3, abortion group + 2.105 Treg cells from nonpregnant CBA/J virgin females intravenously (n = 7); and group 4, abortion group + 2.105 Treg cells from 14-day BALB/c-pregnant CBA/J females intravenously (n = 10). All injections were made intravenously on day 0 to 2 of pregnancy. The data presented in the present study are a mean of two experiments. In a third set of experiments, BALB/c-mated CBA/J female were injected intraperitoneally with anti-CD25 (rat IgG1, clone PC615.3, 125 µg/mouse, n = 8; Exbio Antibodies, Prag, Czech Republic) or with PBS (n = 7).
On day 14 of pregnancy, the females were sacrificed, the uteri removed, and the implantation sites were documented. The abortion sites were identified by their small size accompanied by a necrotic, hemorrhagic appearance, compared with normal embryos and placentas. The percentage of abortions was calculated as the ratio of resorption sites and total implantation sites (resorption plus normal implantation sites) as described previously.17 For in vitro studies, 14-day pregnant normal (BALB/c-mated) or abortion (DBA/2J-mated) CBA/J mice as well as age-matched nonpregnant CBA/J females were included. Four experiments have been performed in which at least three animals have been used.
Treg Cell Isolation
CD4+CD25+ Treg cells were isolated from a mixture containing spleen and thymus cells from nonpregnant or 14-day normal pregnant mice by using magnetic beads following the instructions by the manufacturer (MACS, Miltenyi Biotech, Germany). The purity of the preparations was between 96% and 98% in all experiments. After isolation, Treg cells were washed twice with cold PBS, counted, diluted at 2.105 in 200 µl of PBS, and intravenously injected into pregnant mice or used for the in vitro approaches.
Sample Collection
Spleen and thymus samples were kept in RPMI at 4°C. The uterine horns were opened longitudinally, and the feto-placental unit separated from the uterine implantation sites. The whole placental and decidual unit was separated individually from the respective embryo and its implantation site. Further, placenta and deciduas were carefully separated from each other for flow cytometry and molecular biology but kept together for immunohistochemistry. For flow cytometry, decidual samples were cut in small pieces and collected in Hanks’ balanced salt solution containing no Ca2+ and no Mg2+ (Sigma, Taufkirchen, Germany). For RNA isolation or Western blot, placental and decidual tissues were carefully washed with cold sterile PBS, pH 7.40, snap-frozen, and kept at –80°C until use. For RNA isolation, we exclusively harvested tissues from healthy implantation sites because previous studies from our laboratory failed in obtaining RNA from resorption sites. For immunohistochemistry, tissues were fixed with ethanol 96°C at 4°C.
Flow Cytometry
We isolated mononuclear cells from spleen or thymus by disaggregating the tissue, filtering it through a sterile net (100 µm; BD Biosciences, Heidelberg, Germany), and lysing the erythrocytes with a NHCl4/NaCl solution. Decidual immune cells were obtained as previously described.17
Spleen, thymus, or decidual cells were incubated for 4 hours with 50 ng/ml of phorbol myristate acetate (PMA) (Sigma), 1 µg/µl ionomycin (Sigma), and 20 µmol/L monensin (Sigma) in RPMI (Gibco, Invitrogen, Karlsruhe, Germany) with 10% fetal calf serum (Biochrom AG, Berlin, Germany) in a humidified incubator at 37°C and 5% CO2. Thereafter, the cells were washed, incubated with the surface antibodies for 10 minutes at 4°C in darkness, and fixed with a 1% paraformaldehyde solution overnight at 4°C. On the following day, after permeabilizing the cells with 0.2% saponin, intracellular antibodies were added for 20 minutes at 4°C in darkness. The cells were washed and read on a FACScan flow cytometer from BD Biosciences. Washing steps were performed using washing buffer [1% bovine serum albumin (Sigma) and 0.1% sodium azide (Merck, Darmstadt, Germany)]. The following monoclonal antibodies (mAbs) (purchased from BD Biosciences) were used: fluorescein isothiocyanate-conjugated rat anti-mouse CD4 (rat IgG1), Cy5-conjugated anti-mouse CD8, phycoerythrin-labeled anti-mouse CD25, IL-4, IL-10, IFN-, and TNF- (rat IgG2b). Fluorescein isothiocyanate-, Cy5-, or phycoerythrin-conjugated rat IgG1 or Ig2b were used as negative control in separate tubes.
Real-Time Reverse Transcriptase (RT)-Polymerase Chain Reaction (PCR)
One hundred mg of tissue (placenta or deciduas) were treated with 1 ml of Trizol (Gibco, Life Technologies) and disaggregated using a homogenizator (Ultra Turrax T8; Ika, Germany). The RNA was then extracted with chloroform, precipitated with absolute ethanol, washed, and finally diluted in RNase-free water. The RNA was quantified by reading ultraviolet absorbance at 260 nm. Two µg of total RNA were placed for 2 minutes on ice and added with dNTPs (2.5 mmol/L, Amersham Pharmacia), DNase I (2 U/ml, Stratagene), and RNase inhibitor (40 U/ml, Promega) mixed in reaction buffer. The mix was incubated for 30 minutes at 37°C and further heated to 75°C for 5 minutes. The addition of the reverse transcriptase (200 U/ml, Amersham) and RNase inhibitor in diethyl pyrocarbonate water (diethyl pyrocarbonate from Sigma) started the reverse transcription. This reaction mixture was incubated at 42°C for 60 minutes followed by incubation at 94°C for 5 minutes.
Amplification reactions (13 µl) for foxp3, IL-10, and CD3 consisted of 2 µl of cDNA, 6.25 µl of mastermix containing PCR buffer, dNTPs, MgCl2, and Ampli-Taq DNA polymerase (Eurogentec, Berlin, Germany), 3 µl of the primer mix, 1.25 µl of water, and 0.5 µl of the fluorescent probes. PCR reaction was performed as follows: 2 minutes at 50°C followed by an initial denaturation step of 10 minutes at 95°C, followed by 15 seconds at 95°C, and 1 minute at the appropriate annealing temperature for 40 cycles. All samples were normalized regarding their ß-actin content. All reactions were performed on the ABI Prism 7700 sequence detection system (Perkin Elmer Applied Biosystems). Primer and probe sequences are described in Table 1
.
|
Proteins were extracted from frozen placentas by resuspending them in 350 µl of lysis buffer containing 25 mmol/L CHAPS, 250 mmol/L HEPES, and 25 mmol/L dithiothreitol. It is important to remark that placental extracts were obtained exclusively from healthy implantation sites, because it is impossible to distinguish between placenta and fetus in resorption tissues. The samples were homogenized and protein concentration was assessed in the supernatants using the Bio-Rad Protein Assay (Bio-Rad, Munich, Germany) following the instructions given by the manufacturer. Sixty µg of protein were separated on a 10% sodium dodecyl sulfate-polyacrylamide gel by electrophoresis and transferred to a nitrocellulose membrane (Bio-Rad) 1 hour at 125 mA and 10 W. Membranes were blocked 2 hours at room temperature with Tris-buffered saline (TBS) containing 0.05% Tween and 5% skim milk and thereafter incubated with the first antibody (goat polyclonal antibody against foxp3; Abcam, Hiddenhausen, Germany) at a concentration of 1 µg/ml O.N. at 4°C. After washing three times with TBS + 0.05% Tween, the membranes were incubated with the biotinylated secondary antibody (rabbit anti-goat; DAKO, Hamburg, Germany) for 1 hour at room temperature. After washing, the blots were incubated for 45 minutes with avidin-biotin peroxidase complex. Bands were revealed by chemiluminescence (Amersham, Freiburg, Germany) and exposed onto Kodak Miomax MR Imaging film (Sigma). As a positive control, we used human peripheral blood mononuclear cell extract as suggested by the manufacturer.
Immunohistochemistry
Ethanol-fixed placentas were embedded in paraffin as described before,17
cut at 5 to 7 µm, and conserved at 4°C in darkness. The sections were deparaffinized before immunohistochemistry. After washing with TBS, the sections were heated in 10 mmol/L citrate buffer (pH 6) by pressure cooker and further incubated for 20 minutes with 3% H2O2 in methanol (Sigma) to quench the endogenous peroxidase activity. Nonspecific binding was reduced by blocking the sections with bovine serum albumin (10% bovine serum albumin from Sigma in TBS). The sections were incubated overnight in a humidified chamber at 4°C with the first antibody diluted in 10% bovine serum albumin. The antibodies used were: polyclonal rabbit anti-human progesterone receptor (PR, DAKO) and mouse anti-human estrogen receptor (ER)- (DAKO) as suggested by Kurita and colleagues.29
On the following day, the sections were washed in TBS and incubated at room temperature for 1 hour with the secondary antibody (biotinylated goat anti-rabbit or horse anti-mouse; Vector, Peterborough, UK). After washing, the samples were incubated with an avidin-biotin peroxidase complex solution (DAKO) for 30 minutes at room temperature. 3-amino-9-ethyl-carbazole (AEC) (DAKO for HO-1 and iNOS) or diaminobenzidine (for HO-2 and eNOS, DAKO) were used to visualize the specific immunostaining. The sections were counterstained with hemalaun. The diaminobenzidine-stained sections were then dehydrated and mounted using HistoKit (Roth, Karlsruhe, Germany). The AEC-stained sections were mounted with ultramount medium (DAKO). Negative controls were performed by replacing the first antibody with 10% bovine serum albumin, or 10% nonimmune serum. All sections were analyzed under the light microscope by two independent and blind observers and the expression levels were set by using scores from 0 (no staining) to 5 (very intense staining).
Mixed Lymphocyte Culture: Cytokine Secretion Assay
The MLC was established by mixing 3.5 x 105 spleen or pooled decidual cells from pregnant CBA/J females with 3.5 x 105 3000 rad -irradiated BALB/c or DBA/2J male spleen cells in 0.2-ml cultures in 96-well flat-bottom plates. Previously, effector cells were stained with CFDA-SE (CFSE; Molecular Probes, Eugene, OR) at 1 µmol/L, 107 cells/ml for 3.5 minutes and washed twice with medium containing 10% fetal calf serum. Cells were cultured in RPMI medium (Gibco, Invitrogen) supplemented with 10% fetal calf serum (Biochrom) and antibiotics (Gibco, Invitrogen) and cultured at 37°C for 72 hours. On the third day of culture, cells were added with 50 ng/ml PMA (Sigma) and 1 µg/µl ionomycin (Sigma) for 1 hour. Monensin (20 µmol/L, Sigma) was also added to the culture and the cells were incubated for further 4 hours. Cells were washed, permeabilized with saponin 0.1%, and stained with phycoerythrin-labeled mAb against IFN- or IL-4 (BD Pharmingen) as previously described and read in a FACS-Calibur.
Co-Culture of T Effector and Treg Cells
The MLC was established as described above. Here, 0.15 x 105, 1.5 x 105, or 15.0 x 105 spleen or pooled decidual cells from pregnant CBA/J females were incubated with equal quantities of 3000 rad -irradiated DBA/2J males spleen cells in 0.2-ml cultures in 96-well flat-bottom plates. Cultures were added with 15.0 x 105, 1.5 x 105, or 0.15 x 105 Treg cells obtained from normal pregnant or nonpregnant mice (ratios of T effector:Treg cells were 10:1, 1:1, and 1:10, respectively). Before co-culture, effector cells (spleen or decidual from pregnant CBA/J females) were stained with CFDA-SE (Molecular Probes). Cells were cultured in RPMI medium (Gibco, Invitrogen) supplemented with 10% fetal calf serum (Biochrom) and antibiotics (Gibco, Invitrogen) and cultured at 37°C for 72 hours. On the third day of culture, cells were processed as described previously and analyzed for their proliferation and IFN- production.
Data Analysis and Statistics
All data are presented as medians or medians ± 75% quartiles. As suggested by our statistical advisor because of the characteristics of the groups and the irregular number of samples between the groups, analysis of the differences between all groups was performed using the nonparametric Kruskal-Wallis test. The Mann-Whitney U-test was applied for analyzing differences between two particular groups. The in vitro data are illustrated as mean ± SD from four independent experiments performed. When using pooled samples, significances were analyzed using the 
2 test and -adjusted with Bonferroni’s test. In all cases, P < 0.05 was considered a statistically significant difference.
|
Results |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
As already described by other groups and us,17,28,30
we observed a statistically significant higher abortion rate in the CBA/J x DBA/2J compared to the CBA/J x BALB/c combination (18% versus <1%, P < 0.05; Figure 1A
) although both allogeneic male strains share H2d antigens. Implantation rates were comparable in both combinations (Figure 1B)
. Syngeneic mating combinations, ie, CBA/J x CBA/J matings have no abortions (unpublished observations in n = 9, A.C.Z.).
|
-Producing Paternal Antigen-Specific T Cells in Decidua but Not Spleen of Abortion Mice Compared to Normal Pregnant Mice
Real-time RT-PCR analysis of decidual and placental samples revealed comparable levels of CD3 mRNA in abortion and normal pregnant mice, suggesting a similar T-cell intrauterine infiltration in both combinations (data not shown). Next, we studied the functionality of the decidual T cells by ex vivo stimulation. Decidual cells were harvested and analyzed for their cytokine production after unspecific stimulation with PMA/ionomycin, which is known to stimulate almost all memory/effector T cells to produce cytokines. Decidual lymphocytes from abortion mice produced significantly less IL-10 (Figure 2A)
and more TNF- than decidual cells from normal pregnant mice resulting in significantly diminished ex vivo IL-10/TNF- ratio (Figure 2B)
. In addition, there were comparable frequencies of IFN--producing T cells but slightly lower frequencies of IL-4-producing T cells in the decidua of abortion mice resulting in a marginal but statistically not significant diminution of the IL-4/IFN- ratio (Figure 2C)
.
|
-expressing Th1 memory/effector decidual T cells after stimulation with paternal irradiated splenocytes but not with irradiated syngeneic cells in abortion but not in normal pregnant mice (Figure 2D)
. In contrast, spleen cells of both combinations showed comparable ex vivo cytokine secretion after both PMA/ionomycin (data not shown) and paternal alloantigen stimulation (Figure 2E)
. These data confirm an enhanced intrauterine accumulation of paternal alloantigen-reactive memory/effector Th1 cells in abortion mice. Abortion Mice Presented Diminished Number of CD4+CD25+ and IL-10+ Treg Cells in Thymus When Compared to Normal Pregnant and Nonpregnant Mice
We further wondered whether the accumulation of paternal alloantigen-specific Th1 cells at the feto-maternal interface of abortion mice might be related to diminished Treg activity. We analyzed the number of natural CD4+CD25+ Treg in spleen, thymus, and decidua from normal pregnant and abortion mice by flow cytometry. Interestingly, we found comparable proportion of this T-cell subset in spleen and decidua from both animals groups (data not shown), but a statistically significant increased percentage of Treg in thymus from normal pregnant mice when compared to abortion mice (Figure 3A)
. The latter group expressed even lower levels of CD4+CD25+ T cells than nonpregnant age-matched control mice (Figure 3A)
. These data suggest that high levels of CD4+CD25+ Treg have been generated in the thymus during normal pregnancy, which could not be achieved in the abortion combination. Remarkably, the thymus of abortion mice presented less CD8+CD25+ T cells than normal pregnant and normal nonpregnant mice (0.26% versus 1.86% versus 1.78%, respectively; P < 0.05). This cell population may also have regulatory properties. Decidual tissue from both combinations presented high numbers of CD4+CD25+ T cells (median, 5%). However, activated effector CD4+ cells also express CD25, therefore this marker may not be useful for quantifying Treg at the site of immune activation.
|
. In addition, the diminished frequency of ex vivo IL-10-secreting decidual T cells (Figure 2, A and B)
suggests a Treg deficiency in the decidua from abortion mice. A lower foxp3 mRNA and protein expression—an essential transcription factor of naturally occurring Treg—in placenta of abortion mice supports this view (Figure 3, C and D)
.
CD4+CD25+ Treg Cells Inhibit Paternal Alloantigen-Induced Proliferation and IFN- Production by Decidual T Cells from Abortion Mice in Vitro
Next, we addressed the question whether the addition of Treg might reverse the cellular abnormal cell response in abortion-prone mice. To analyze the in vitro effect of Treg on T-cell proliferation and cytokine production, we stimulated decidual or spleen cells from abortion CBA/J mice with male (DBA/2J) APCs and added to the culture Treg cells from nonpregnant or normal pregnant CBA/J mice in different proportions. Very interestingly, we observed a Treg number-dependent inhibition of alloantigen-induced proliferation of decidual cells (Figure 4A)
. Additionally, a less inhibited proliferation of spleen lymphocytes could be observed (Figure 4B)
. The inhibitory effect could be observed after addition of Treg from both nonpregnant or normal pregnant mice. Similarly, the frequency of IFN--secreting allostimulated decidual (Figure 5A)
was significantly inhibited after addition of Treg from both nonpregnant and normal pregnant mice. Spleen cells produced less IFN- after allostimulation if co-cultured with Treg cells (Figure 5B)
.
|
|
To verify the hypothesis that Treg cells play a protective role during pregnancy as suggested by our in vitro data, we isolated CD4+CD25+ cells from thymus and spleen of 14-day normal pregnant mice (BALB/c-mated CBA/J females) or age-matched nonpregnant CBA/J female mice as for the in vitro experiments described above. Treg cells (2 x 105) were adoptively transferred into 0- to 2-day pregnant abortion-prone mice. Very interestingly, the transfer of CD4+CD25+ Treg cells from normal pregnant but not from nonpregnant CBA/J mice completely prevented spontaneous abortion (Figure 6)
. Notably, transfer of spleen Treg or thymus Treg had the same effect than the mixture (n = 3 each, data not shown). Additionally, the Treg transfer failed to prevent abortion if made on days 4 to 5 of pregnancy (data not shown), suggesting that Treg cells are necessary locally for successful implantation to take place.
|
and a significant up-regulation (twofold to fivefold) of IL-10 mRNA expression (Figure 7, C and D)
at day 14 in decidua and placenta of abortion-prone mice after application of Treg from normal pregnant mice suggesting an accumulation of Treg at the fetal-maternal interface. However, a similar up-regulation of both foxp3 (1.3-fold) and IL-10 (1.5- to 5-fold) was observed in placenta and decidua after transfer of Treg from nonpregnant female mice, which did not prevent abortion (Figure 7
; A to D). These data suggest that Treg from both normal pregnant and nonpregnant mice are able to infiltrate the feto-maternal interface but only those Treg cells previously exposed to paternal alloantigens have protective regulatory activity in vivo.
|
To test the hypothesis that Treg cells are necessary before the implantation period—probably by suppressing potentially harmful cells locally—we treated normal pregnant mice (CBA/J x BALB/c) with a monoclonal antibody against CD25 or with PBS on day 0 of pregnancy. The anti-CD25 treatment resulted in a decrease in the percentage of pregnant mice per total mated mice (37.5%) as compared to the controls (100%, Table 2
).
|
Because immune dysfunction may contribute to infertility through the negative effects on the reproductive endocrine system, we decided to analyze the impact of our treatment on the hormonal receptivity of the mice by semiquantifying the levels of the receptors for progesterone (PR) and estrogen (ER). As shown in Figure 8
, treatment of the animals with Treg from normal pregnant animals but also with Treg from nonpregnant animals led to increased expression of progesterone receptor, suggesting that not only hormonal changes are necessary for pregnancy success. The estrogen receptor expression was not modified by the application of Treg.
|
|
Discussion |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
To study the key role of Treg in pregnancy, we used the murine CBA/J x DBA/2J abortion combination, which has been used for years to investigate immunological pathways leading to spontaneous abortion.28 Certified strains of CBA/J mice (H2k) originally from the Jackson Laboratories, but not CBA/C spontaneously show high abortion rates when mated with H2d-bearing DBA/2J but do not abort if mated with other H2d-bearing male such as BALB/c suggesting a role of minor MHC antigens.9,28,30 The abortion rate seems also to be related to the characteristics and conditions of the animal husbandry, because differences in abortion rates between laboratories have been reported.28 In our facilities, CBA/J x DBA/2J combination shows 18 to 30% abortion, whereas CBA/J x BALB/c usually presents no abortion events with comparable implantation rates in both combinations. Thus, the CBA/J x DBA/2J model is a reliable model for analyzing mechanisms underlying immunological spontaneous abortions.
Cytokines were proposed to play a crucial role in mammalian pregnancy success. The Th1/Th2/Th3 paradigm proposes that Th2- and Th3-type cytokines such as IL-4, IL-10, and transforming growth factor (TGF)-ß may favor the maintenance of mammalian pregnancy,6,10-12
whereas the excessive production of Th1 cytokines (IL-2, IFN-, TNF-) would mediate the rejection of the fetus at the feto-maternal interface.10,13-17
Nevertheless, this hypothesis was questioned in the last 3 years, because 1) the combination of IL-4 and IL-10 knockout mice resulted in normal pregnancies, suggesting that neither maternal, nor fetal production of IL-4 or IL-10 is crucial for the completion of pregnancies;18
2) the placental cells from the abortion-prone mating combination expressed and secreted less IL-18 than the nonabortion mating combination;20
and 3) blood and decidual cells from patients suffering from spontaneous abortion produced less IL-12 than cells from normal pregnant patients.21
The fact that IL-10- and IL-4-deficient mice are having normal pregnancies points out that none of these cytokines are crucial for fetal survival.18 Unfortunately, no data on possible abortion events (resorptions) were provided in the study by Svensson and colleagues,18 because they documented only living neonates after spontaneous delivery which do not rule out resorptions/abortions. Although IL-4 and IL-10 are related to successful pregnancy outcome in humans and mice6,9,32-34 and the administration of IL-10 inhibited the abortion rate in the CBA/J x DBA/2J model.32 Other immunosuppressive molecules, especially TGF-ß, have been proposed to play an important role during pregnancy.35,36 It is tempting to speculate that in the IL-10/IL-4 knockout mice, the lack of IL-10 or IL-4 could be covered or by-passed by high levels of other immunosuppressive molecules, ie, TGF-ß. No reports confirm this hypothesis. Interestingly, TGF-ß2 and -ß3 play very important roles in development as observed in TGF-ß2- and -ß3-deficient mice.37 Accordingly, White and colleagues38 pointed out that although IL-10 is not essential for tolerance or successful pregnancy irrespective of MHC disparity in the fetus, maternal IL-10 is a determinant of growth trajectory in progeny in uterus and after birth.38
Here, we analyzed the ex vivo ability of spleen and decidual lymphocytes from abortion and normal mice on day 14 of pregnancy to produce Th1 and Th2 cytokines after unspecific stimulation with PMA/ionomycin as well as after specific stimulation with male antigens. Previous data indicated diminished IL-4 and IL-10 production by whole placenta cultures as well as low IL-4 and IL-10 expression in placental tissues from the CBA/J x DBA/2J combination when compared to CBA/J x BALB/c.32-34
High ex vivo placental levels of TNF- and IL-6 have been reported for this murine abortion model,14,17
being placental and stroma decidual cells the major producers of these cytokines. Further, it has been reported that placental cells derived from the abortion-prone combination CBA/J x DBA/2J are able to induce a Th1-like response in responder lymphocytes and furthermore, that when these stimulated lymphocytes are adoptively transferred to normal pregnant mice, they induce fetal resorption.39
Although, no studies concentrated on the ex vivo ability of spleen and decidual immune cells to produce Th1/Th2 cytokines as an in vivo mirror of immune cell imprinting. We found comparable CD3+ T-cell infiltration at the feto-maternal interface as well as PMA/ionomycin inducible Th1 memory/effector T cells in the two mating combinations but an enhanced frequency of paternal alloantigen-specific Th1 memory/effector lymphocytes in abortion mice, suggesting, as Tangri and colleagues39
did, production of detrimental cytokines by Ag-specific T cells as a cause of abortion. On the contrary, spleen cells showed comparable polyclonal and paternal alloantigen-specific Th1 frequencies in both combinations. These data demonstrate that the generation of polyclonal Th1 memory/effector cells and their homing to the tissues including the uterus is not influenced by pregnancy. In addition, systemic generation of paternal alloantigen-specific Th1 memory/effector cells is not inhibited during normal pregnancy but their activity is down-regulated at the feto-maternal interface. This fact suggests the existence of specific regulatory processes, which would control Th1 cells that are specific against paternal alloantigen. The diminished frequency of IL-10- and IL-4-producing decidual T cells after polyclonal stimulation and the significantly lower proportion of CD4+CD25+ and IL-10+ T cells in the thymus of abortion mice suggest a deficient immunoregulation.
There are a lot of evidences from human and mice studies that CD4+CD25+ T cells have immunoregulatory activity: they are named as T regulatory cells (Treg). Treg cells have a role in preventing graft-versus-host disease and their adoptive transfer could protect skin grafts from rejection.40 Further, tolerance could be adoptively transferred by transferring Treg from long-time surviving cardiac allograft.41 Treg cells were shown to in vitro inhibit Th1 but not Th2 responses42 as well as proliferation of Th1 effector cells by secreting IL-10 and TGF-ß.43 Because IL-10 is produced by activated Treg cells, a lower frequency of IL-10-producing T cells in abortion mice may be an indicator of diminished Treg frequency/activity. Treg can exert their actions not only by secreting IL-10 and other immunomodulatory cytokines but also by contact-dependent inhibition, particularly of APC.43 Thus, the lower number of IL-10+ decidual T cells as well as the lower foxp3 mRNA and protein expression in our model might reflect disturbed Treg generation. The lower decidual IL-4 production in abortion mice might further contribute to diminished Treg activity because IL-4 is not produced by Treg but it acts synergistically with Treg in organ transplant models.44
Very recently, while preparing this article, Aluvihare and colleagues45 described the role of natural Treg in mediating maternal tolerance to the fetus in a normal pregnancy model. They observed an expansion of CD4+CD25+ T cells in almost all tissues of pregnant compared to nonpregnant female mice independently on the paternal MHC difference. Like in our study, in vitro analysis showed an inhibitory capacity of CD4+CD25+ T cells on maternal alloresponses. CD25+ T-cell depletion led to gestation failure suggesting an active role of Treg in mediating maternal tolerance to the fetus.45 However, CD25 antibody may inhibit not only Treg but also other immune cells, such as activated lymphocytes in a late pregnancy state. In the present study, we demonstrate for the first time the pathophysiological consequences of diminished Treg activity in pregnancy, namely spontaneous abortion. The successful prevention of abortion by adoptive transfer of Treg from normal pregnancy in our model first confirmed the impact of Treg for pregnancy outcome and is very relevant clinically. Additionally, two very recent human studies support the important role of Treg in human pregnancy as well.46,47
Next, we wondered what could be the reason for diminished Treg generation and activity in abortion-prone mice, which could help to elucidate diminished Treg levels observed in patients undergoing abortion.47 Decidual tissue presented relatively high levels of CD4+CD25+ T cells and no differences could be observed between controls and abortion-prone mice, maybe because of the fact that CD25 may also mark activated cells in decidua. We observed comparable numbers of Treg cells in spleen from both experimental groups but a significant diminution in the number of CD4+CD25+ and IL-10+ Treg cells in thymus from abortion mice when compared to normal pregnant mice. The latter group showed a dramatic increase in the number of CD4+CD25+ thymocytes when compared to age-matched nonpregnant mice suggesting an enhanced Treg generation in the thymus during normal pregnancy. Moreover, CD4+CD25+ T cells from both normal pregnant and nonpregnant mice were able to in vitro suppress the maternal alloresponse of lymphocytes from abortion-prone mice and accumulated at the feto-maternal interface of these mice after adoptive transfer as shown by enhanced decidual foxp3 and IL-10 expression. Remarkably, however, Treg from normal pregnant but not from nonpregnant mice could protect fetal rejection in vivo. The data suggest that alloantigen (H2d in our model) stimulation of Treg is required for mediating their protective effects in vivo. Similar observations were made in organ transplantation models. Natural CD4+CD25+ T cells as well in vitro generated genetically modified alloreactive IL-10-expressing T cells suppressed the alloresponse of naive T cells in vitro but were unable to prolong allograft survival in vivo (Brandt C and colleagues, unpublished observations).25
In the light of our results, in vivo (allo)antigen priming of Treg may be required for optimal Treg activity protecting allogeneic fetuses from rejection, as described for allotransplants. As we observed dramatic differences in the number of Treg in the thymus of normal pregnant versus abortion-prone mice it is tempting to speculate that the thymus plays a role in generation of both natural Treg43 as well as pregnancy-induced Treg. This would require fetal antigens, passing through the thymus. Previous data suggest an immunomodulatory role for the thymus during pregnancy.48 In mice, the weight of the thymus falls by 75% because of a massive depletion of cortical thymocytes while medullary thymocytes remain unaffected.49,50 However, the thymus remains functional.51,52 Moreover, the thymic involution seems to be a physiological process necessary for the success of normal pregnancy52 and the placenta was proposed to be a crucial player in thymic involution by affecting thymocyte properties during their maturation in the thymic microenvironment.48,53 Using an in vitro co-culture system, Savion and Toder48 were able to show that placental or decidual explants from normal pregnant mice had inhibitory effect on thymocyte proliferation. The bi-directional transfer of cells between mother and fetus has been a matter of debate but it is now accepted that such an exchange is in fact taking place in the placenta.54,55 Accordingly with these observations and our data on up-regulated levels of Treg cells in thymus from normal pregnant mice but not from pregnant mice undergoing abortion, it is very probably that placenta-derived antigens enter the thymus and provoke the generation of immunoregulatory cells, which would avoid fetal rejection. Our data would further explain why the transfer of thymocytes from multiparous mice provoked tolerance to male skin grafts.56 The in vitro co-culture of thymocytes and placental/decidual extracts further led to a lower IL-6 production.48 Accordingly with the in vitro data and because increased IL-6 levels are known to be associated with abortion17 it is tempting to speculate that placental antigens prime the cytokine production by thymocytes to a regulatory profile. We propose that placental antigens generated in the CBA/J x BALB/c but not CBA/J x DBA/2J combination regulate the generation of Treg as well as the suppressive cytokine production, ie, IL-10. Which factor is generating Treg cells in one combination and not in the other is still unknown.
Whether the immunoregulatory activity of Treg cells is antigen-specific, it is still a matter of discussion,23,42,56,57,58 but at least in stronger systems such as allotransplantation there are evidences for their antigen specificity.59 As both mating combinations share the paternal MHC type, Treg generated to BALB/c can specifically protect maternal anti-DBA/2J responses as well, both by direct or indirect allorecognition which might be the dominant pathway for immunoregulation by CD4+CD25+ cells.58,59 Interestingly, Chaouat and colleagues60 reported in 1983 that abortion rates in CBA/J female mice mated with DBA/2J males could be dramatically reduced by vaccination with BALB/c male spleen cells, but not by CBA/J or DBA/2 J male spleen cells. Further, this effect correlated with the ability of BALB/c spleen cells to induce MLR suppressor activity in CBA/J female mice.60 In the light of our results, we can speculate that in the experiments by Chaouat and colleagues60 the transfer of BALB/c male splenocytes generated Treg cells in DBA/2J-mated CBA/J females and avoided therefore immunological abortion.
Recently, Erlebacher and colleagues61
showed very nicely that an immune failure of mouse pregnancy by anti-CD40 treatment was mediated by impaired progesterone synthesis by the ovary as well as by TNF- production. In our preliminary analysis of hormonal receptivity, we found that the transfer of Treg from both nonpregnant and pregnant mice restored the expression levels of PR as analyzed on day 14 of pregnancy. ER expression was not influenced by Treg transfer. These data suggest that solely hormonal changes are not enough to revert abortion events. Ag specificity by Treg may be indispensable for pregnancy success.
Finally, it appears that Treg cells are effective before implantation takes place as suggested by the experiments blocking Treg cells by anti-CD25 on day 0 of pregnancy as well as by the fact that pregnancy-induced Treg are not effective if applied on days 4 to 5 of pregnancy. Which mechanisms underlie these phenomena remain to be elucidated and should be the focus of next studies.
In summary, our study indicates that normal pregnant mice show no differences in the generation of polyclonal and paternal antigen-specific Th1 response compared to abortion-prone mice. However, the decidual accumulation of paternal alloantigen-specific but not of polyclonal Th1 memory/effector cell is significantly inhibited in successful pregnancy. The accumulation of paternal alloantigen-specific Th1 cells at the decidua of abortion mice seems to be because of insufficient generation of pregnancy-induced Treg. Here, we show for the first time that adoptive transfer of Treg from normal pregnancy protects against fetal rejection in abortion-prone mice. This understanding might have an important impact on specific immunotherapy of fetal loss by spontaneous abortion and other immunological-related pregnancy complication, such as pre-eclampsia.
|
Acknowledgements |
|---|
|
Footnotes |
|---|
Supported by grants from the Charité (UFF 2003-109 and 2003-230 to A.C.Z. and a Ph.D. fellow to M.L.Z.).
Accepted for publication November 30, 2004.
|
References |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various auto-immune diseases. J Immunol 1995, 155:1151-1164[Abstract]
. Am J Reprod Immunol 1995, 154:4261-4268
This article has been cited by other articles:
 |
|
 |
|
  J. Mjosberg, J. Svensson, E. Johansson, L. Hellstrom, R. Casas, M. C. Jenmalm, R. Boij, L. Matthiesen, J.-I. Jonsson, G. Berg, et al. Systemic Reduction of Functionally Suppressive CD4dimCD25highFoxp3+ Tregs in Human Second Trimester Pregnancy Is Induced by Progesterone and 17{beta}-Estradiol J. Immunol., July 1, 2009; 183(1): 759 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schumacher, N. Brachwitz, S. Sohr, K. Engeland, S. Langwisch, M. Dolaptchieva, T. Alexander, A. Taran, S. F. Malfertheiner, S.-D. Costa, et al. Human Chorionic Gonadotropin Attracts Regulatory T Cells into the Fetal-Maternal Interface during Early Human Pregnancy J. Immunol., May 1, 2009; 182(9): 5488 - 5497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Robertson, L. R. Guerin, J. J. Bromfield, K. M. Branson, A. C. Ahlstrom, and A. S. Care Seminal Fluid Drives Expansion of the CD4+CD25+ T Regulatory Cell Pool and Induces Tolerance to Paternal Alloantigens in Mice Biol Reprod, May 1, 2009; 80(5): 1036 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Guerin, J. R. Prins, and S. A. Robertson Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum. Reprod. Update, March 11, 2009; (2009) dmp004v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chattopadhyay, J. O'Rourke, and R. E. Cone Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells Int. Immunol., April 1, 2008; 20(4): 509 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Habicht, S. Dada, M. Jurewicz, B. T. Fife, H. Yagita, M. Azuma, M. H. Sayegh, and I. Guleria A Link between PDL1 and T Regulatory Cells in Fetomaternal Tolerance J. Immunol., October 15, 2007; 179(8): 5211 - 5219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kokeny, M. Godo, E. Nagy, M. Kardos, K. Kotsch, P. Casalis, C. Bodor, L. Rosivall, H-D. Volk, A.C. Zenclussen, et al. Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice Lupus, July 1, 2007; 16(7): 465 - 477. [Abstract] [PDF]
|
|
|
|
|
|
I. Guleria and M. H. Sayegh Maternal Acceptance of the Fetus: True Human Tolerance J. Immunol., March 15, 2007; 178(6): 3345 - 3351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Arruvito, M. Sanz, A. H. Banham, and L. Fainboim Expansion of CD4+CD25+and FOXP3+ Regulatory T Cells during the Follicular Phase of the Menstrual Cycle: Implications for Human Reproduction J. Immunol., February 15, 2007; 178(4): 2572 - 2578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Jasper, K. P. Tremellen, and S. A. Robertson Primary unexplained infertility is associated with reduced expression of the T-regulatory cell transcription factor Foxp3 in endometrial tissue Mol. Hum. Reprod., May 1, 2006; 12(5): 301 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Miwa, S. Hayakawa, S. Miyazaki, S. Myojo, Y. Sasaki, M. Sakai, O. Takikawa, and S. Saito IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-{gamma} increase in normal pregnancy but decrease in spontaneous abortion Mol. Hum. Reprod., December 1, 2005; 11(12): 865 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sollwedel, A. Z. Bertoja, M. L. Zenclussen, K. Gerlof, U. Lisewski, P. Wafula, B. Sawitzki, C. Woiciechowsky, H.-D. Volk, and A. C. Zenclussen Protection from Abortion by Heme Oxygenase-1 Up-Regulation Is Associated with Increased Levels of Bag-1 and Neuropilin-1 at the Fetal-Maternal Interface J. Immunol., October 15, 2005; 175(8): 4875 - 4885. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
